IP Library › Granted Patent US 11,066,406
Granted Patent B2
US 11,066,406 · App. 16/776,243 · Granted Jul 20, 2021

Small molecule inhibitors of the JAK family of kinases

Inventors: Philippe Fernandes (Turnhout, BE); Paul J. Krawczuk (Newtown, PA); Mark S. Tichenor (San Diego, CA)
Assignee: Janssen Pharmaceutica NV
C07D471/14C07B2200/13
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,066,406
App. No.
16/776,243
Granted
Jul 20, 2021
Kind
B2
Abstract

2-((1r,4r)-4-(imidazo[4,5-d]pyrrolo[2,3-b]pyridin-1(6H)-yl)cyclohexyl)acetonitrile compounds, pharmaceutical compositions containing them, methods of making them, and methods of using them including methods for treating disease states, disorders, and conditions mediated by JAK.

Claims (1)

1. A compound of formula

Continuity (5)
Continuation 16581018 · Sep 24, 2019
Continuation 16441656 · Jun 14, 2019
Provisional Application 62846290 · May 10, 2019
Provisional Application 62685737 · Jun 15, 2018
Related Publication 20200165250A1 · May 28, 2020